drugset / Trial / NCT01211470
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study investigates the safety and efficacy of PMX-30063 in patients treated for acute bacterial skin and skin-structure infection (ABSSSI).
Timeline
- Start
- 2010-10
- Primary completion
- 2011-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Daptomycin | Other / unclassified | — | — |
| Subject | PMX-30063 | Unknown | — | — |